All Ords

Tuesday is shaping up to be rough one for many All Ordinaries Index (ASX: XAO) shares. Fortunately, not all are suffering.

It has since slipped slightly to $1.1725, representing a 1.96% gain. [ASX: ARX](https://www.fool.com.au/tickers/asx-arx/)). However, earlier today, it hit $2.50 – marking an 8.7% gain and the highest the stock has been in 18 months. [earnings before interest, tax, depreciation, and amortisation (EBITDA)](https://www.fool.com.au/definitions/ebitda/) was positive. [its half-year performance](https://www.fool.com.au/tickers/asx-arx/announcements/2022-11-29/2a1416780/aroa-biosurgery-half-yearly-results-h1-fy23/), dropped in late November. [return on investment (ROI)](https://www.fool.com.au/definitions/return-on-investment/). [ASX: PNV](https://www.fool.com.au/tickers/asx-pnv/)). [healthcare](https://www.fool.com.au/investing-education/healthcare-shares/) favourite to explain today’s rise. [announced the end](https://www.fool.com.au/tickers/asx-pnv/announcements/2022-12-16/3a609780/successful-completion-of-share-purchase-plan/) of a $53 million [capital raise](https://www.fool.com.au/definitions/capital-raising/) – offering new shares for $1.90 apiece.